nedaplatin has been researched along with Carcinoma, Small Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kijima, H; Kusumi, T; Nakamura, M; Nishime, C; Ohnishi, Y; Sato, F; Suemizu, H; Tamaoki, N; Ueyama, Y; Yamazaki, H | 1 |
| Schiller, JH | 1 |
| Arioka, H; Funayama, Y; Heike, Y; Nishio, K; Ogasawara, H; Ohira, T; Saijo, N; Takahashi, M | 1 |
| Aragane, K; Kitada, O; Matsuyama, T; Meguro, T; Nakahama, H; Nakamura, H; Nishioka, Y; Sugita, M; Takamitsu, Y; Takenaka, Y; Tanimukai, T; Yano, T | 1 |
| Fukumoto, H; Kanzawa, F; Koh, Y; Koizumi, F; Nakamura, T; Nishio, K; Saijo, N; Tatsumi, Y; Yoshioka, T | 1 |
| Ariyoshi, Y; Fujii, M; Fukuoka, M; Furuse, K; Hasegawa, K; Kurita, Y; Niitani, H; Nishiwaki, Y; Tamura, M; Yoneda, S | 1 |
| Nakai, Y | 1 |
| Eguchi, K; Ohe, Y; Ohmori, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Hiraki, S; Kiura, K; Kozuka, A; Mima, Y; Moritaka, T; Ohnoshi, T; Ueoka, H; Uji, H; Yamashita, H; Yonei, T | 1 |
2 review(s) available for nedaplatin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Small cell lung cancer: defining a role for emerging platinum drugs.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum Compounds; Recurrence | 2002 |
[Development of platinum analogues for the treatment of lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds | 1992 |
2 trial(s) available for nedaplatin and Carcinoma, Small Cell
| Article | Year |
|---|---|
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Organoplatinum Compounds | 1992 |
[Development of platinum analogues for the treatment of lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds | 1992 |
6 other study(ies) available for nedaplatin and Carcinoma, Small Cell
| Article | Year |
|---|---|
In vivo chemotherapeutic profile of human gallbladder small cell carcinoma.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Deoxycytidine; Docetaxel; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Mice, Nude; Organoplatinum Compounds; Taxoids; Xenograft Model Antitumor Assays | 2008 |
In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cisplatin; Drug Resistance; Female; Humans; Lung Neoplasms; Mice; Mice, SCID; Neoplasm Transplantation; Organoplatinum Compounds; Tumor Cells, Cultured | 1995 |
[Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Humans; Kidney Failure, Chronic; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Renal Dialysis | 1999 |
In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; DNA Topoisomerases, Type I; Drug Synergism; Enzyme Inhibitors; Humans; Irinotecan; Lung Neoplasms; Organoplatinum Compounds; Thiazoles; Thiazolidinediones; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2001 |
Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Topics: Antineoplastic Agents; Biological Assay; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Tumor Cells, Cultured | 1991 |
[Comparison of the antitumor activity of newly developed platinum analogs in lung cancer using the colony assay].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Line; Cisplatin; Humans; In Vitro Techniques; Lung Neoplasms; Organoplatinum Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |